Related Experiment Video

Updated: Jun 11, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

MAPKs are not involved in triptolide-induced cell growth inhibition and apoptosis in prostate cancer cell lines with

Wei Li1, Yong Liu, Xue-Xia Li

  • 1Laboratory of Pharmaceutical Resource Discovery, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China.

Planta Medica
|July 8, 2010
PubMed

Insights

Triptolide effectively inhibits prostate cancer cell growth and induces apoptosis, independent of p53 status. Mitogen activated protein kinases (MAPKs) are not involved in triptolide

Area of Science:

  • Pharmacology
  • Oncology
  • Molecular Biology

Background:

  • Triptolide exhibits significant antitumor properties against various solid tumors.
  • The precise mechanism underlying triptolide's anticancer activity remains incompletely elucidated.
  • Understanding triptolide's effects on prostate cancer is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the role of mitogen activated protein kinases (MAPKs) in mediating triptolide's activity in human prostate cancer cell lines.
  • To determine if p53 status influences triptolide's efficacy and mechanism of action.

Main Methods:

  • Utilized LNCaP (p53 positive, androgen-dependent) and PC-3 (p53 deficient, androgen-independent) prostate cancer cell lines.
  • Assessed the effects of triptolide on cell growth inhibition and apoptosis.
  • Investigated the involvement of ERK and JNK pathways using specific inhibitors following triptolide treatment.

Main Results:

  • Triptolide demonstrated potent growth inhibitory and apoptotic effects on both LNCaP and PC-3 cells.
  • These observed effects were independent of the p53 expression status of the cell lines.
  • While triptolide treatment upregulated ERK and JNK phosphorylation, pathway inhibitors indicated these MAPKs are not critical to triptolide's mechanism.

Conclusions:

  • Triptolide possesses significant anticancer activity against prostate cancer cells, irrespective of p53 expression.
  • The mitogen activated protein kinase (MAPK) pathways, specifically ERK and JNK, do not appear to mediate triptolide's cytotoxic effects in these models.
  • Further research is warranted to fully elucidate the molecular targets and pathways responsible for triptolide's potent antitumor activity.

More Related Videos

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...